ReportCutaneous malignant melanoma in association with mycosis fungoides☆
Section snippets
Case reports
We describe 6 patients (4 men, 2 women) with cutaneous malignant melanoma (MM) in association with MF. The clinical details are summarized in Table I. The mean age of onset of MF was 46.5 years (range: 26-69 years). At diagnosis 2 patients had stage IA, 2 patients had IB, and 2 patients had IIA disease. No patient has developed more advanced lymphoma (median follow-up: 9 years).
The mean age at diagnosis of melanoma was 51.8 years (range: 27-67 years). The mean Breslow thickness of the 5 cases
Discussion
Retrospective analysis of the first 461 cases entered into our cutaneous lymphoma database revealed 285 cases of MF. Among these cases of MF were 6 patients who also had a MM. In these 6 patients the cutaneous lymphoma was diagnosed first in 4 cases and the melanoma first in 2 cases. During the period of follow-up, 2 patients developed metastatic melanoma but none had progression of their MF.
An increased incidence of both melanoma and nonmelanoma skin cancer has previously been reported in
Acknowledgements
We are grateful to Catherine Dolbear (information analyst) and Helen Evans (researcher) of TCR for calculating the expected and observed coexistence of MM and MF in the Thames region.
References (25)
The risk of melanoma in association with long-term exposure to PUVA
J Am Acad Dermatol
(2001)- et al.
Small malignant melanoma in patients with mycosis fungoides
J Eur Acad Dermatol Venereol
(1998) - et al.
Malignant melanoma in renal transplant patients
Lancet
(1981) - et al.
Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomas
J Invest Dermatol
(1999) Risk factors for the development of primary cutaneous malignant melanoma
Dermatol Clin
(2002)- et al.
Frequent abnormalities of the p15 and p16 genes in mycosis fungoides and Sézary syndrome
J Invest Dermatol
(2002) - et al.
P16(INK4a) is selectively silenced in the tumoral progression of mycosis fungoides
Lab Invest
(2002) - Kantor AR, Curtis RE, Vonderheid EC, Van Scott EJ, Fraumeni JF Jr. Risk of second malignancy after cutaneous T-cell...
- et al.
Secondary malignant neoplasms in 71 patients with Sézary syndrome
Arch Dermatol
(1999) Cancer registration in England, 1998
(2001)
Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphomathe influence of additional therapy after total skin electron beam radiation
Arch Dermatol
Cited by (0)
- ☆
Funding sources: None.
Conflicts of interest: None identified.